G. W. O’Neil et al. / Tetrahedron Letters 54 (2013) 715–717
717
4. (a) Coval, S. J.; Scheuer, P. J. J. Org. Chem. 1985, 50, 3024; (b) Carter, K. P.; Moser,
D. J.; Storvick, J. M.; O’Neil, G. W. Tetrahedron Lett. 2011, 52, 4494.
5. Cimino, G.; Passeggio, A.; Sodano, G.; Spinella, A.; Villani, G. Cell. Mol. Life Sci.
1991, 47, 61.
6. Peltarri, E.; Matikainen, J.; Elo, H. Z. Naturforsch. 2002, 57, 548.
7. Julia, M.; Paris, J. M. Tetrahedron Lett. 1973, 14, 4833.
18. Mengel, M.; Reiser, O. Chem. Rev. 1999, 99, 1191. and references cited therein.
19. Examples of non-selective additions to aldehydes of this type: (a) Ehrlich, G.;
Hassfeld, J.; Eggert, U.; Kalesse, M. Chem. Eur. J. 2008, 14, 2232; (b) Dounay, A.
B.; Urbanek, R. A.; Frydrychowski, V. A.; Forsyth, C. J. J. Org. Chem. 2001, 66, 925.
20. Select examples: (a) Wilson, K. J.; van Niel, M. B.; Cooper, L.; Bloomfield, D.;
O’Connor, D.; Fish, L. R.; MacLeod, A. M. Bioorg. Med. Chem. Lett. 2007, 17, 2643;
(b) Labelle, M.; Belley, M.; Gareau, Y.; Gauthier, J. Y.; Guay, D.; Gordon, R.;
Grossman, S. G.; Jones, T. R.; Leblanc, Y. Bioorg. Med. Chem. Lett. 1995, 5, 283; (c)
Jackson, R. H.; Morrissey, M. M.; Sills, M. A.; Jarvis, M. F. J. Pharmacol. Exp. Ther.
1992, 262, 80.
21. Pyridine 2-alkenylation: (a) Mousseau, J. J.; Bull, J. A.; Charette, A. B. Angew.
Chem. I. E. 2010, 49, 1115; (b) Murakami, M.; Hori, S. J. Am. Chem. Soc. 2003, 125,
4720; (c) Kanyiva, K. S.; Nakao, Y.; Hiyama, T. Angew. Chem. I. E. 2007, 46, 8872;
(d) Kanyiva, K. S.; Nakao, Y.; Hiyama, T. J. Am. Chem. Soc. 2008, 130, 2448; (e)
Cho, S. H.; Hwang, S. J.; Chang, S. J. Am. Chem. Soc. 2008, 130, 9254; Pyridine 3-
alkenylation: (f) Ye, M.; Gao, G.-L.; Yu, J.-Q. J. Am. Chem. Soc. 2011, 133, 6964.
22. Storvick, J. K.; Ankoudinova, E.; King, B. R.; Van Epps, H.; O’Neil, G. W.
Tetrahedron Lett. 2011, 52, 5858.
8. Previous synthesis: (a) Achmatowicz, O.; Maruszewska-Wieczorkowska, E.;
Michalski, Y. Rocz. Chemii 1955, 29, 1029–1039
(b) For an alternative synthesis see Supplementary data.
9. Brandl, T.; Hoffmann, R. W. Eur. J. Org. Chem. 2002, 2613.
10. Bordwell, F. G.; Van der Puy, M.; Vanier, N. R. J. Org. Chem. 1976, 41, 1885.
11. Zoltewicz, J. A.; Helmick, L. S. J. Org. Chem. 1973, 38, 658.
12. Buemel, O. F.; Smith, W. N.; Rybalka, B. Synthesis 1974, 43.
13. This is consistent with a more recent estimate of 2-picoline pKa = 34. See:
Fraser, R. R.; Mansour, T. S.; Savard, S. J. Org. Chem. 1985, 50, 3232.
14. (a) Gianelli, C.; Lopez, R.; Puente, Á.; Zalacain, M.; Palomo, C. Eur. J. Org. Chem.
2012, 2774; b) Rotulo-Sims, D.; Prunet, J. Org. Lett. 2007, 9, 4147.
15. Konishi, K.; Yoshino, A.; Katoh, M.; Takahashi, K.; Kawada, Y.; Sugawara, T.;
Iwamura, H. Bull. Chem. Soc. Jpn. 1981, 54, 3117.
23. Comparison of substituted heterocycle acidities: DePuy, C. H.; Kass, S. R.; Bean,
G. P. J. Org. Chem. 1988, 53, 4427.
24. Complex sulfone alkylation: Mahapatra, S.; Carter, R. G. Org. Biomol. Chem.
2009, 7, 4582.
16. Song, J. J.; Tan, Z.; Gallou, F.; Xu, J.; Yee, N. K.; Senanayake, C. H. J. Org. Chem.
2005, 70, 6512.
17. The stereochemistry of alcohol 13 was determined by detailed NMR analysis
after conversion to the corresponding acetal:
OTBS
1. TBAF
H
O
N
N
2. CSA,
C(OMe)2Me2
H
O
OH
(70%, 2-steps)
nOe
See Supplementary data for details.